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Getting the right prescription for
rehabilitation after stroke
Clinicians working with stroke survivors believe that
poststroke rehabilitation works, but the evidence base
to convince a wider audience is lacking. There are sev-
eral contributory factors for this. First, we do not
know how much of an intervention to provide,
although the differences in outcome due to an extra
30 hours1 compared to 300 hours2 of upper limb
treatment suggests more is better. Second, we are
not sure when to intervene, although the heightened
effect of training due to injury-induced biological
events seen early after stroke in rodent models (so-
called spontaneous biological recovery3) suggests
earlier is better. Third, because clinical trials in neuro-
rehabilitation are often not based on mechanistic
principles, they lack the appropriate stratification that
might identify the appropriate subgroups where large
clinically meaningful effect sizes are possible.4 In
other words, there are clues but they often seem to
be ignored. Consequently, it appears difficult to move
past the proof of principle study and the failure to
translate advances in neuroscience into improved
stroke outcomes continues.5 This all adds up to a
challenging time for those interested in promoting
recovery after stroke.
As a consequence, the A Very Early Rehabilitation
Trial for Stroke (AVERT) trial6 was greeted with
enthusiasm. Here was a thoughtfully designed study
asking whether earlier and more rehabilitation is bet-
ter. Specifically, the rationale of the original AVERT
study was that at least 3 additional sessions of sitting,
standing, and walking activity started within 24 hours
of stroke would improve favorable outcome 3 months
after stroke (defined as a modified Rankin Scale score
of 0–2). It was reasoned that earlier, more frequent,
and higher amounts of out of bed activity after stroke
could reduce immobility-related complications and
take advantage of spontaneous biological recovery to
improve outcomes. The flip side was that impaired
cerebral autoregulation might lead to reduced cerebral
perfusion with an increase in upright posture, thereby
exacerbating ischemia. The AVERT results were pub-
lished last year and demonstrated that 3-month
outcomes were better in the usual care group than
in those mobilized early. The possible reasons for this,
including mortality due to stroke recurrence or pro-
gression, have been discussed elsewhere.7 Further-
more, although described as a trial of activity, this
interpretation ignores the obvious point that
increased activity can be achieved while patients
remain in bed,8 which in fact may be more beneficial
to upper limb recovery.
AVERT took 8 years to recruit and the results
were much anticipated. After publication of the pri-
mary results, there was a general sense of disappoint-
ment that there was no green light to earlier and more
aggressive physical therapy, which many had sug-
gested was needed to augment recovery. There was
some concern that the results would be used to cut
back “unnecessary” early neurorehabilitation teams.
However, AVERT has more insights regarding
early poststroke rehabilitation, as investigators delved
further into their results. Crucially, the investigators
were careful to record details of all interventions,
thereby allowing for prespecified “dose” response
analyses to examine the effect of (1) time from stroke
onset to first mobilization out of bed, (2) number of
out-of-bed sessions per patient per day, and (3) mi-
nutes of out-of-bed activity per patient per day. In
this issue of Neurology®, Bernhardt et al.9 report that
additional sessions (given constant time to first mobi-
lization and minutes of out-of-bed activity) improved
the odds of achieving a favorable outcome (defined as
a modified Rankin Scale score of 0–2). However,
increasing the amount of time spent in out-of-bed
activity (given constant number of sessions and time
to first mobilization) reduced the odds of a favorable
outcome. Taken together, these findings indicate that
short, frequent sessions of mobilization may be pref-
erable for many stroke survivors in the first weeks
after stroke, a result that is altogether more clinically
useful than the primary analysis.
AVERT was aimed at increasing sitting, standing,
and walking, so does this study tell us anything about
rehabilitation of stroke more generally? It is tempting
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to suggest that the results might generalize. In the
upper limb, for example, newly learned skills are more
likely to be retained when there are frequent and lon-
ger rest periods between training sessions.10 The au-
thors are cautious about the results, suggesting that
each of these factors (number and length of treatment
sessions) will need to be assessed prospectively in ran-
domized clinical trials. The implications for early
upper limb training, while supine or upright, are also
likely to require separate investigation.
For now, however, this study provides clinically use-
ful data that help to fill an important gap in our knowl-
edge about the optimal dose (frequency and timing) of
mobilization in the early stages after stroke. Impor-
tantly, it completely changes the narrative that had
begun after the publication of the primary outcomes.
It highlights the complexity of decision-making that
is involved in stroke rehabilitation, and reminds us that
therapy schedule, not just the total amount and timing,
matters. The design of future clinical trials needs to
take this into account by investigating whether these
principles apply to all neurorehabilitation interventions
in general. This further analysis of the AVERT study
provides further clues to finding the right prescription
for early rehabilitation after stroke.
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